[Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D003982:Dibekacin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013183:Sputum / Q000378:metabolism
D000900:Anti-Bacterial Agents; D003982:Dibekacin; D007612:Kanamycin